Pregabalin misuse skyrockets
Pregabalin-related ambulance attendances have increased 10-fold since 2012, a Victorian study has shown.
Published in the Medical Journal of Australia, the retrospective study on the...
Raft of NSW COVID restrictions; updated ATAGI advice
New South Wales has recorded 16 new locally acquired COVID-19 cases, with Premier Gladys Berejiklian announcing new restrictions today to stop the spread.
PSA champions equal healthcare for the LGBTIQA+ Australians
atients from LGBTQIA+ communities continue to experience poor health outcomes. How can pharmacists provide inclusive care to these patients?
What went right (and wrong) with Australia’s COVID-19 response?
COVID-19 enquiry criticises delays involving pharmacists in rollout, calling for urgent harmonisation of vaccine scope.
Using interpreters to communicate critical pharmacy advice
The Department of Social Services (DSS) has released further information to support pharmacists in their use of the Free Interpreting Service available to community...
RTPM experiences: How it works well
Real-time prescription monitoring provides some, but not all information in supplying Controlled Drugs and other high-risk medicines. Here’s how it can help
